Dengue virus and dendritic cells

Nature Medicine

Volumn 6, Issue 7, 2000, Pages 748-749

  Palucka, Anna Karolina ^a  

^a BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SUBPOPULATION; DENDRITIC CELL; DENGUE; DENGUE VIRUS; HUMAN; IMMUNOPATHOGENESIS; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRUS CELL INTERACTION;

CELL DIFFERENTIATION; DENDRITIC CELLS; DENGUE; DENGUE VIRUS; HUMANS; LANGERHANS CELLS; SKIN;

DENGUE VIRUS; FLAVIVIRUS;

EID: 0033915304     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/77470     Document Type: Short Survey

References (13)

1. Steinman, R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296 (1991).
2. Banchereau, J. et al. Immunobiology of dendritic cells. Ann. Rev. Immunol. 18, 767 (2000).
3. Caux, C. et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor α: II. Functional analysis. Blood 90, 1458-1470 (1997).
4. Ferlazzo, G., Klein, J., Paliard, X., Wei, W.Z. & Galy, A. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells. J. Immunother. 23, 48-58 (2000).
5. Siegal, F.P. et al. The nature of the principal type 1 interferon-producing cells in human blood. Science 284, 1835-1837 (1999).
6. Geijtenbeek, T.B. et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587-597 (2000).
7. Grosjean, I. et al. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. .J Exp. Med. 186, 801-812 (1997).
8. Wu, S. et al. Human skin Langerhans cells are targets of dengue virus infection. Nature Med. 6, 816-820 (2000).
9. Monath, T. in Infectious diseases (eds. Mandell, G.L., Douglas, R.G.Jr. & Bennett, J.E.) (Churchill Livingstone, NY, 1990).
10. Velzing, J. et al. Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines. Vaccine 17, 1312-1320 (1999).
11. Gagnon, S., Ennis, F. & Rothman, A. Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones. J. Virol. 73, 3623-3629 (1999).
12. Kurane, I., Meager, A. & Ennis, F. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production and cytotoxic activity. J. Exp. Med. 170, 763-775 (1989).
13. Huang, J. et al. Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever. J. Med. Virol. 57, 1-8 (1999).